SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-015276
Filing Date
2024-02-14
Accepted
2024-02-14 16:31:06
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rnlx-20231231.htm   iXBRL 10-Q 2056823
2 EX-3.1 rnlx-ex3_1.htm EX-3.1 700634
3 EX-31.1 rnlx-ex31_1.htm EX-31.1 11542
4 EX-31.2 rnlx-ex31_2.htm EX-31.2 12049
5 EX-32.1 rnlx-ex32_1.htm EX-32.1 7522
6 GRAPHIC img83610915_0.jpg GRAPHIC 17069
  Complete submission text file 0000950170-24-015276.txt   9108450

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20231231.xsd EX-101.SCH 1576958
72 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20231231_htm.xml XML 1208472
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39387 | Film No.: 24639115
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)